Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Women with Gestational Diabetes Need Retesting After Pregnancy

By HospiMedica International staff writers
Posted on 12 May 2010
Women who have had gestational diabetes should be retested for diabetes 6 to 12 weeks after the baby is born, and at least every three years after that. More...
Follow-up screening usually consists of a simple blood test.

Generally, steps are taken to manage gestational diabetes during pregnancy for the health of both mother and child. However, many women do not realize that if they have had gestational diabetes they are at increased risk for developing diabetes in the future, and their child is also at increased risk for obesity and type 2 diabetes.

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; Bethesda MD, USA) and the Office of Research on Women's Health (ORWH; Bethesda, MD, USA) are together promoting awareness of risks attached for mothers and children after pregnancies where there had been gestational diabetes. A special effort was made from May 9-15, 2010, which included Mother's Day in many parts of the world, and [US] National Women's Health Week.

"Many women think that if the follow-up test after the baby is born shows no signs of diabetes, they are in the clear, but that is not the case," said Vivian Pinn, M.D., director of the ORWH. "What many of these moms do not know is that they have a 40 % to 60 % chance of developing diabetes as early as five to 10 years after their baby is born. These women need to know this information and they need to take steps to lower their risk for developing diabetes."

Related Links:
U.S. National Institute of Diabetes and Digestive and Kidney Diseases
Office of Research on Women's Health



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hybrid Arch Device
Neo EDE
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.